Assessment of Inhibition of Biofilm Formation and Plaque Bacterial Count of Fluoride Varnish Containing Chlorhexidine and Cetylpyridinium Chloride Versus Conventional Fluoride Varnish

NCT04254835 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

High Caries Risk Patients

Interventions

DRUG: Cervitec F, Ivoclar Vivadent - Schaan Liechtenstein
DRUG: Fluor Protector, Ivoclar Vivadent - Schaan Liechtenstein

Sponsor

Cairo University